chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My left deltoid muscle is still aching at 7 weeks after this first injection.  I first noticed after 5-6 days when the expected initial pain of the shot subsided. I thought it would go away soon, but only realized that it would not when my right shoulder was fine 3 days after my 2nd shot. I have received my 2nd COVID vaccine 4 weeks after on Feb 9 in the right deltoid. There is no aching or adverse effects in my right arm at the time of this report.  I have reason to believe that the first shot was given too high in the left shoulder and possible SIRVA is the result in my left deltoid shoulder joint.   I use ibuprofen 800mg 3x daily, and that doesn?t take all the aching away. It is a persistent ache that doesn?t interfere with my ability to work, yet it limits my ability to do upper body exercises.
Excursion duration refrigerator was below 36°F for 2 hours and 45 minutes total; vaccine administered after an excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion duration refrigerator was below 36°F for 2 hours and 45 minutes total) and EXPIRED PRODUCT ADMINISTERED (vaccine administered after an excursion) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Dec-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion duration refrigerator was below 36°F for 2 hours and 45 minutes total) and EXPIRED PRODUCT ADMINISTERED (vaccine administered after an excursion). On 21-Dec-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion duration refrigerator was below 36°F for 2 hours and 45 minutes total) and EXPIRED PRODUCT ADMINISTERED (vaccine administered after an excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Vaccine was administered intramuscularly in the upper deltoid muscle to the patient. No treatment information was reported.
this pt. has a raised bump at or around the vaccine location site of a size of a dime, no treatment no outcome, no redness some tenderness and it is not growing in side.
Patient received influenza on the right arm, and PREVNAR on the left arm on 10/2/17. Patient reports following adverse reactions on 10/4/17 at the pharmacy. Patient reports that on 10/3/17 her RIGHT ARM started hurting during the day time and started burning in the middle of the night. On 10/4/17, patient reports she saw redness, inflammation, and swelling. Patient reports local reaction only and denies any systemic reactions. Patient came to the pharmacy on 10/4/17 and reported these adverse reactions.
24 hours  post vaccine-- numbness and tingling bilateral  plantar aspect of the feet which resolved Several hours later-- shock like impulses that initiated at the feet. 48 hours post vaccine-- ascending shock like impulses from feet to legs, pelvis, abdomen/back, chest and then face with the area distally improving as the proximal area is affected in a wave like fashion.
received first dose of the Moderna vaccine in mid May and wants to get the second dose today; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (received first dose of the Moderna vaccine in mid May and wants to get the second dose today) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (received first dose of the Moderna vaccine in mid May and wants to get the second dose today). At the time of the report, PRODUCT DOSE OMISSION ISSUE (received first dose of the Moderna vaccine in mid May and wants to get the second dose today) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.   Reporter did not allow further contact
I am having vaginal bleeding, started with spotting on 11Apr, turned to mostly bright red blood on 12Apr, heavier on 13Apr, no change on 14Apr; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient herself). A 58-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0153), dose 1 via an unspecified route of administration, administered in Arm Left on 06Apr2021 15:00 (03:00 pm) as dose 1, single (at age of 58-years old) for covid-19 immunization. The patient's medical history included known allergies: allergic to sulfa drugs and patient had an adverse reaction to Non-steroidal anti-inflammatory drugs (NSAIDs). The patient had menopausal. The patient's concomitant medication/other medications in two weeks included unspecified medication. The patient had no other vaccine in four weeks. The patient had no covid prior vaccination. The patient was not covid tested post vaccination. The patient stated, she was post-menopausal. She was having vaginal bleeding, started with spotting on 11Apr2021, turned to mostly bright red blood on 12Apr2021, heavier on 13Apr2021, no change on 14Apr2021 (today). The event resulted in doctor or other healthcare professional office/clinic visit. The patient not received treatment for the adverse event. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. There we no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 06-JUN-2016, the patient was vaccinated with an expired dose of ROTATEQ lot# K015816, expiration date: 29-MAY-2016, orally (exact dose was not reported). There were no adverse effects noted. Additional information has been requested.
It was the 1st dose after talking to the doctor on site and they put me in for extra observation (30 Mins). Within 12 minutes I had an allergic reaction and I spent a good two hours plus with them and now I am on the CDC watch app.  The two paramedics plus doctor said they had never seen a person have all the symptoms in one shot, till they met me. The doctor said he was amazed at how sensitive my body was to the medicine but was very impressed that I had all my medications, allergic reactions and so on digitally. I go for the 2nd/final shot on 4/29 so hopefully that one doesnt have me down for days bc I leave for the DR on 5/1. I have been home and recovering sine Thursday.  I had a fever, chills, my arm went numb, then I had swelling/redness and sore to the touch, chest palpitations, my asthma kicked in with the wheezing, my blood pressure sky rocketed, my sugar jumped up to 300, fatigue, tiredness, then the itching started and diarrhea. Just a lot going on from one shot.
Covid Arm....itching 10 days after injection and then redness of local site and burning in the arm. Pictures available.
Lots of Redness , slight pain and swelling eight days after the shot . No signs of improvement  I notice more flare up when I?m using that arm or in the sun.
Patient reports having a temperature of 104 degrees F. for 2 days, sore left arm with swelling. Symptoms subsided by Monday
2 days post vax, itching, burning rash to toes, feet swollen light headed, treated and resolved but reoccurred 2 weeks later, also was taking new heart medication, has multiple allergies.
One (left) side of face, lip was swollen.  Left eye was closed due to swelling.  Neck glands swelling.  He got the vaccine on left arm.
A couple weeks after my booster I began to get overwhelmingly itchy. I developed dermatographia that caused my body to have a strong immune response to small scratches. My skin gets inflamed and hives break out. Itchiness and burning ensues. A bit of a never ending cycle until I consciously stop myself from scratching.
Low grade fever lasting less than six hours - noticed 10 hours after vaccine (around midnight) went back to sleep. Fever seemed resolved by morning. Pain in injection site radiating up into neck and throughout shoulder, starting 18 hours after injection and lasting 36 hours.
Patient received moderna vaccine on 1/22/21, 2/19/21 and 10/22/21. Presented to ER on 6/19/22 and found to be COVID19 positive. Initial admission patient acute kidney injury abnormal LFT.  Bilirubin was normal alk phos was 61. Patient was found to have problem the COVID positive but due to his abnormal labs, see rounding MD note, not a candidate for remdesivir at that time.  Was treated with Decadron. Patient condition fluctuated.  He also was hypotensive and little bit of shock.  Treated with appropriate measures at that time.  He had improved for couple days then again started getting worse. 48 hours prior to this patient again started having experiences significant increased amount of shortness of breath.  Chest x-ray still shows infiltrate. Patient remains afebrile Patient does not want BiPAP and wanted more comfort measures and was placed on comfort measures.  Due to severity of shortness of breath and distress, patient was placed on IV morphine drip. He expired today as expected. This morning when I saw him, at that time patient was comfortable.  Mild tachypnea but no distress.  Not much respond to any verbal stimuli suggesting that he was comfortable overall. Yesterday was very restless and very uncomfortable. He expired 7/1/22 as expected under proper comfort measures.
Patient's physician's office called to report the child spiked a 104'F temperature with a cough and congestion. No flu swab performed. Spoke with Mother on 3/10/2020; Mother states child still ill with respiratory symptoms and returning to physician today 3/10/2020.
Vomiting and severe stomach pain. 1st episode 4/14-25 hospital stay 2nd episode 5/20-present  Vomiting and severe stomach pain
diagnosed with COVID; This is a spontaneous report from a contactable consumer (wife) or other non hcp. A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 23Mar2021 as 1st dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 28Mar2021, Yesterday, the patient was diagnosed with COVID-19. The patient had felt terrible and had fevers and these are the symptoms of COVID-19. The patient was scheduled to second dose on 13Apr2021. The patient wants to know how long they (patient and her husband) should wait to get the second vaccine, considering their COVID diagnosis. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch cannot be obtained.
The patient reported a rash which developed the evening of 7/9/19. She described a bluish colored lace pattern on her abdomen which spread to arms and legs. There was no itching or fever. She was seen in the emergency room 7/14/19. Abdominal xray and urinalysis were performed and she was treated with Miralax for constipation. She followed up with me (Dr.) on 7/19/19. The lace-patterned rash was still present on her abdomen, forearms, and anterior/inner thighs although improved from photos mother showed me from her cell phone. We continued to treat constipation, ordered imaging of the abdomen and referred to Allergy and immunology for further recommendations regarding future vaccinations.
Positive nose bleed. Fever to 103, headaches, light sensitivity, myalgias, back pain, neck soreness (Neck supple on exam) within 24 hrs after receiving vaccine.
day following vax pt devel erythema on site of immun; warm, no pain, no fever, no wheezing
This case was reported by a consumer via call center representative and described the occurrence of lower abdominal pain in a female patient who received SHINGRIX for prophylaxis. On 29th November 2018, the patient received the 2nd dose of SHINGRIX. On 29th November 2018, less than a day after receiving SHINGRIX, the patient experienced lower abdominal pain and pain in arm. On an unknown date, the outcome of the lower abdominal pain and pain in arm were unknown. It was unknown if the reporter considered the lower abdominal pain and pain in arm to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received SHINGRIX a day before reporting at 11:30. The patient's arm was really sore, which was expected. The patient did not expect a debilitating really sharp pains in her lower right quadrant, which started at night on the day of vaccination and continued on the day of reporting. The pain was so sharp that it doubles her over and brings tears to her eyes. The patient asked if this was a normal side effect.
Stomach cramps; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramps) and DIARRHOEA (Diarrhea) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products ADALIMUMAB (HUMIRA) for Panuveitis and COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for COVID-19 vaccination.    No Known allergy. No relevant medical history.    On 23-Jun-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jun-2022, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. On an unknown date, the patient received first dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, received second dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jun-2022, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramps) and DIARRHOEA (Diarrhea). At the time of the report, ABDOMINAL PAIN UPPER (Stomach cramps) and DIARRHOEA (Diarrhea) outcome was unknown.            Concomitant medications details were not reported.  The patient took Moderna vaccine as a booster dose. The patient received Humira (solution for injection in pre-filled pen) with the dosage citrate free (40 mg,1 in 2 week) for non-infectious intermediate, posterior and panuveitis.  It was unknown if patient was enrolled in a covid-19 vaccine trial.   The reporter's causality for the events of diarrhea and severe stomach cramps with Humira(adalimumab) and Janssen covid-19 vaccine was a  reasonable possibility.  No treatment medication were provided.
Patient fell ill w/ sx of Fever, chills, bodyaches, nausea the night after the vaccination. No other sx were noticed until 2 days after vaccination, which then patient began to notice a rash that spread from vaccine site, across chest and in to the left forearm. Patient was seen by physician on the 3rd day post vaccine. Patient was rx steroids (Prednisone) for the rash and Zyrtec.
Mother called advice nurse morning after vaccines with report of whelps around injection site that extends form above her buttocks around the waist to below the knee on the L side only.
This spontaneous report as received from a physician assistant refers to a patient of unknown age and gender. The patient's medical history and current conditions were not provided. Physician assistant reported that patient was administered the series of GARDASIL outside the recommended dosing schedule. The first dose of GARDASIL (unspecified lot, expiration date, dose and route were unspecified) was administered on 20-APR-2015. The second dose of GARDASIL (unspecified lot, expiration date, dose and route were unspecified) was administered on 22-MAY-2015 and the third dose of GARDASIL (unspecified lot expiration date, dose and route were unspecified) was administered on 23-JUN-2015. No adverse experience has been reported. Additional information has been requested.
Headache, fever, muscle aches other than injection site, soreness at inj. site, malaise.
Intense full body itching, headache, swelling on upper lip. mild throat tightness. Treated with Benadryl, Ibuprofen,  mild itching persists (6 days)
Redness and swelling at site of injection. Came in the day after reaction was localized.
Acute Hives (Urticaria) started slightly the next day (Sat 6/18) and was significant on Sunday (6/19). Have been on anti-histamines (Allegra 180 mg three times daily). Flare-up around 6/27 - 6/28 timeframe. Two weeks later, the symptoms are still severe (acute urticaria). Required a steroid injection (50 mg) on 6/28. Did not have much effect. Primary Care physician put me on Steroid (medrol pack) from 6/29, that has helped slightly. The hives are on the face (unrecognizable with swelling / inflammation) , neck, chest, back, and legs (all over the body)
On 2/9 this employee received 2nd COVID immunization, woke up on Wednesday, found that his hearing was muffled in left ear. On Thursday, the employee reports he had no hearing in left ear, with some tinnitus. On Friday, he went to see primary care, primary care thought she saw fluid behind both ears, put him on flunase and mucinex; after consulting with his sister who is a NP, he went to see the doctor audiology, they saw him on 2/16, he was diagnosed with sudden "sensireoneural hearing loss". He was prescribed a two week course of prednisone to treat this condition by the doctor. Has begun taking the prednisone. States that he is still without hearing in his left ear, continues to have tinnitus in that ear.
Patient felt dizzy and fell to floor. She felt lightheaded and was sweating and pale once she sat up. She was given an ice pack and 911 was called. EMS transported her to the hospital.
it wasn't available in my local pharmacy; This case was reported by a consumer via interactive digital media and described the occurrence of product supply issue in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 27th May 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced product supply issue. On an unknown date, the outcome of the product supply issue was unknown.   Linked case(s) involving the same patient:  GB2022085933   Additional Information: GSK Receipt Date: 27-MAY-2022 and 8-June-2022 Reporter's Comments: The patient self-reported this case. The patient never got the second shot.  The patient stated that when it was time to take the second dose, it was not available in his/her local pharmacy. The patient's pharmacist suggested that he/she wrote to the manufacturer of the vaccine. The patient asked could he/she just did one more shot or did he/she have to do the 2 shot regimen 6 months apart. The patient's doctor did not know, and the pharmacist said he/she should contact GlaxoSmithKline.  The patient wanted to know do he/she need to take both shots again or just one more injection. Additional Supportive Information: When it was time to take the second dose, it was not available in his/her local pharmacy, which led to product supply issue. The case GB2022085933 was identified as duplicate of this case. The case GB2022085933 was deleted and all future correspondence would be added in the present case which stands as case of record for this patient.
At around 530 I started to experience chest pain and shortness of breath. I had cramping in my left arm. It was then followed by about a week and a half of erratic heart beats and erratic blood pressure. The pain in my chest ended after two weeks or so. I called and consulted with emergency room physicians who told me that I did not have serious enough heart attack or stroke symptoms and therefore not to come in. They categorize this as some kind of information of the heart related to the vaccination, but it was too early in the process to have a lot of information about pericarditis or myocarditis.
Patient reports that approximately 1/2 hour after receiving his COVID vaccination, he experienced numbness and tingling in his left arm, the same arm that he was vaccinated. He describes it extending down to his elbow and up to his shoulder. It also progressed to his neck and face to a small extent. He denies any other symptoms such as swelling, hives, shortness of breath,  or throat tightness. He states it subsided after about 8 hours. Today the numbness and tingling started again as he used his arm at work, but intermittently. Advised to report this reaction to his PCP, to seek emergent evaluation with any progression of symptoms. He states understanding, and will get clearance from his PCP regarding any further COVID vaccinations in the future.
On 1/30/04 had body aches, low grade fever, flu like symptoms. On 2/2/04 had jaundice. On 2/3/04 had diffuse macular papular body rash. On 2/7/04 was hospitalized. Still in hospital on 2/10/04.
This spontaneous report as received from a Licensed Practical Nurse refers to an unspecified number of patients of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. Between 18-AUG-2015 and 21-AUG-2015, an unspecified number of patients were vaccinated with unspecified doses in series of improperly stored VAQTA lot # L007559, expiry date 01-JUN-2017 (dose, site and route of administration were not reported). No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd vax & w/in 6hrs exp one episode of vomiting;
Two days after her second Pfizer COVID-19 vaccine, my daughter developed a vaginal sore. She has never experienced anything like this before. It was painful to her. I treated with some ointment that we had at home, and it resolved on its own within a couple of days.
Severe right shoulder pain and riht arm pain.  Patient denies any reddness or severe swelling just pain.
Patient had cellulitis of right arm that started just at the injection site. Redness and swelling spread down into forearm and parents brought him to the ER. Itching was also noted on ED notes.